Home |
About Us |
Investor Relations |
Products & Services |
Science & Technology |
People |
News & Events |
Contact Us
News |
Events
|
|
 |
|
||
 |
||
| |
|
 |
 |
28 November 2007 Director Share Purchases Cyprotex PLC (AIM: CRX), the drug discovery technology and information company was notified today that Robert Morrison Atwater, the Chairman and Chief Executive of the Company purchased a total of 225,000 ordinary shares of 0.1p each in the Company on 27 November 2007 at 5.10 pence per share. Robert Morrison Atwater now has a total interest of 1,835,000 ordinary shares in the Company, which represents 1.32% of the issued share capital of the Company. For further information:
|
|
|
 |
|
 |
Legal
Disclaimer |